Myriad Genetics
MYGN
#7319
Rank
C$0.75 B
Marketcap
C$7.83
Share price
-1.44%
Change (1 day)
-13.73%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2026 (TTM): C-$1.92

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is C-$1.95. In 2025 the company made an earnings per share (EPS) of C-$5.65 a decrease over its 2024 EPS that were of C-$2.02.

EPS history for Myriad Genetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.92-66.04%
2025C-$5.65179.43%
2024C-$2.02-55.94%
2023C-$4.59130.22%
2022C-$1.99275.68%
2021C-$0.53-87.99%
2020C-$4.42755.56%
2019C-$0.52-194.74%
2018C$0.54-79.89%
2017C$2.71112.36%
2016C$1.28-35.97%
2015C$1.99-7.33%
2014C$2.15-37.24%
2013C$3.4359.33%
2012C$2.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
C$3.88-298.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
C-$7.63 291.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C-$0.13-93.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
C-$72.99 3,642.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C$54.72-2,905.88%๐Ÿ‡บ๐Ÿ‡ธ USA